MedTrace Logo

Malaria in Pregnancy: Nutrition and Immunologic Effects

NCT01115478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2500

Last updated 2015-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of zinc and/or vitamin A supplementation in reducing the risk of placental malaria and its associated adverse pregnancy outcomes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin A

Daily oral dose of 2500 IU from enrollment until delivery

DIETARY_SUPPLEMENT

Zinc

Daily oral dose of 25 mg from enrollment until delivery

OTHER

Placebo

Daily oral dose from enrollment until delivery

Sponsors & Collaborators

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Wafaie W Fawzi, MD, DrPH · Harvard School of Public Health (HSPH)

  • Ferdinand Mugusi, MD, MMed · Muhimbili University of Health and Allied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01115478 on ClinicalTrials.gov